News & Analysis on Clinical Trial Services & Contract Research And Development
As the European Medicines Agency (EMA) has implemented the majority of elements of the new pharmacovigilance legislation, the agency is now reporting that the main objectives of the legislation are largely being achieved.
Scientists are scouring the seas for novel bioactive compounds as part of PharmaSea, a four-year project which has already turned up interesting compounds from samples of mud, sediment and sea life.
The US FDA is proposing a new rule that would allow the agency to destroy a drug valued at $2,500 or less that has been refused admission into the US.
Medpace Laboratories, Singapore will serve and support new and existing Medpace pharmaceutical clients conducting clinical research in the rapidly expanding Asia Pacific region.
Teva will close eleven of its manufacturing plants and is considering shutting another 16 as part of a campaign to cut annual spending by $2bn (€1.4bn).
Huntingdon Life Sciences has acquired contract research and animal models firm Harlan Laboratories, making it the third largest preclinical research organisation, according to the company.
AMRI has upped its guidance following a quarter that saw unprecedented demand from its once-troubled Burlington plant and the integration of recent acquisition Cedarburg commence.